Navidea Biopharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NAVB and buy or sell other stocks, ETFs, and their options commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. 

CEO
Michael S. Rosol, PhD
CEOMichael S. Rosol, PhD
Employees
Employees
Headquarters
Columbus, Ohio
HeadquartersColumbus, Ohio
Founded
1983
Founded1983
Employees
Employees

NAVB Key Statistics

Market cap
100.00
Market cap100.00
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.81K
Average volume2.81K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.05
52 Week high$0.05
52 Week low
52 Week low

Stock Snapshot

The current Navidea Biopharmaceuticals(NAVB) stock price is $1.61, with a market capitalization of 100.

On 2026-03-10, Navidea Biopharmaceuticals(NAVB) stock opened at —, reached a high of —, and a low of —.

The Navidea Biopharmaceuticals(NAVB)'s current trading volume is 0, compared to an average daily volume of 2.81K.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.